Advertisement
Advertisement
U.S. markets open in 4 hours 16 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Misonix, Inc. (MSON)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
25.63-0.15 (-0.58%)
At close: 4:00PM EDT
Advertisement

Misonix, Inc.

1938 New Highway
Farmingdale, NY 11735
United States
631 694 9555
http://www.misonix.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees281

Key Executives

NameTitlePayExercisedYear Born
Mr. Stavros George Vizirgianakis B.Com.CEO & Director967.57kN/A1970
Mr. Joseph P. DwyerCFO, Treasurer & Sec.506.95kN/A1956
Mr. Robert Scott LudeckerSr. VP of Global Sales & Marketing429.22kN/A1967
Dr. Allan Richard StaleyPresN/AN/A1960
Ms. Sharon W. KlugewiczChief Operating OfficerN/AN/A1968
Dr. Arti B. Masturzo M.D.Chief Medical OfficerN/AN/AN/A
Mr. Jonathan WaggonerExec. VP of Global Sales - WoundN/AN/A1966
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator, which is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system that provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

Corporate Governance

Misonix, Inc.’s ISS Governance QualityScore as of September 26, 2021 is 8. The pillar scores are Audit: 9; Board: 8; Shareholder Rights: 7; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement